The DOI matches its Crossref record; the references it cites are not checked yet.
Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme.
Abstract
Objective To characterise the pharmacokinetic-pharmacodynamic relationships for linezolid efficacy. Design and study population Retrospective nonblinded analysis of severely debilitated adult patients with numerous comorbid conditions and complicated infections enrolled under the manufacturer's compassionate use programme. Methods Patients received intravenous or oral linezolid 600 mg every 12 hours. Plasma concentrations were obtained and a multicompartmental pharmacokinetic model was fitted. Numerical integration of the fitted functions provided the area under the concentration-time curve over 24 hours (AUC), the ratio of AUC to minimum inhibitory concentration (AUC/MIC) and the percentage of time that plasma concentrations exceeded the MIC (%T>MIC). Main outcome measures Modelled pharmacodynamic outcomes of efficacy included probabilities of eradication and clinical cure (multifactorial logistic regression, nonparametric tree-based modelling, nonlinear regression) and time to bacterial eradication (Kaplan-Meier and Cox proportional hazards regression). Factors considered included AUC/MIC, %T>MIC, site of infection, bacterial species and MIC, and other medical conditions. Results There were 288 cases evaluable by at least one of the efficacy outcomes. Both %T>MIC and AUC/MIC were highly correlated (Spearman r2 = 0.868). In our analyses, within specific infection sites, the probability of eradication and clinical cure appeared to be related to AUC/MIC (eradication: bacteraem…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some studies in critically ill patients have reported benefits in terms of clinical cure [237, 250–253].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [251]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 24 · Cited by 306
Research works printed but not linked: 2
- Jernigan, 1996, MMWR Morb Mortal Wkly Rep, 45, 1
- Slatter, 2001, Drug Metab Dispos, 29, 1136
Metadata
- Authors
- Rayner, C. R., Forrest, A., Meagher, A. K., Birmingham, M. C., & Schentag, J. J.
- Affiliations
- Monash University (AU)
- University at Buffalo, State University of New York (US)
- Venue
- Clinical Pharmacokinetics
- Published
- 2003
- Volume
- 42
- Issue
- 15
- Pages
- 1411-1423
- ISSN
- 0312-5963 (ISSN-L)
- OpenAlex
- W2003136021
- Semantic Scholar
- 2a37b15179a75208de083703902aff2e8745d997
- Cited by
- 306
- References
- 24
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 16 · 2023: 8 · 2022: 23 · 2021: 16 · 2020: 24 · 2019: 11 · 2018: 13 · 2017: 20 · 2016: 14 · 2015: 21 · 2014: 21 · 2013: 13 · 2012: 11
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Pharmacokinetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- linezolid, pharmacodynamics, pharmacokinetics, AUC/MIC, time above MIC, bacterial killing, clinical cure, bacteremia, skin and skin structure infections, lower respiratory tract infection, bone infection, complicated infections, compassionate use
- MeSH terms
- Linezolid, Acetamides, Adolescent, Adult, Aged, Aged, 80 and over, Anti-Infective Agents, Female, Humans, Liver, Male, Microbial Sensitivity Tests, Middle Aged, Retrospective Studies, Severity of Illness Index, Comorbidity, Logistic Models, Treatment Outcome, Gram-Positive Bacterial Infections, Area Under Curve, Oxazolidinones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme. https://app.cochat.ai/papers/10.2165/00003088-200342150-00007
- The paper
- Rayner, C. R., Forrest, A., Meagher, A. K., Birmingham, M. C., & Schentag, J. J. (2003). Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme. Clinical Pharmacokinetics. https://doi.org/10.2165/00003088-200342150-00007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.